This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB9M0BY_M.jpg
Medtronic announced earnings per share of $0.62 on revenue of $6.51B. Analysts polled by Investing.com anticipated EPS of $0.18 on revenue of $5.4B.
Medtronic shares are down 11% from the beginning of the year, still down 18.03% from its 52 week high of $122.15 set on January 22. They are under-performing the S&P 500 which is up 6.21% from the start of the year.
Medtronic’s report follows an earnings beat by Merck&Co on July 31, who reported EPS of $1.37 on revenue of $10.87B, compared to forecasts EPS of $1.06 on revenue of $10.4B.
Pfizer had beat expectations on July 28 with second quarter EPS of $0.78 on revenue of $11.8B, compared to forecast for EPS of $0.68 on revenue of $11.54B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
